CD44 and ovarian carcinoma: Hyaluronic acid-decorated carriers frequently exploit CD44 to deliver cytotoxins [101] or to deliver MDR1 siRNA selectively to chemoresistant CD44-overexpressing ovarian cancer cells [102].